评估早期乳腺癌复发风险：整合临床与基因组风险 - Suppr

Suppr

超能文献

Estimating Risk of Recurrence for Early Breast Cancer: Integrating Clinical and Genomic Risk.

作者信息

Dowsett Mitch, Turner Nicholas

机构信息

Royal Marsden Hospital, London, United Kingdom.

Institute of Cancer Research, London, United Kingdom.

出版信息

J Clin Oncol. 2019 Mar 20;37(9):689-692. doi: 10.1200/JCO.18.01412. Epub 2019 Feb 11.

DOI:10.1200/JCO.18.01412

PMID:30742561

Abstract

摘要

相似文献

Estimating Risk of Recurrence for Early Breast Cancer: Integrating Clinical and Genomic Risk.

J Clin Oncol. 2019 Mar 20;37(9):689-692. doi: 10.1200/JCO.18.01412. Epub 2019 Feb 11.

A 23-gene prognostic classifier for prediction of recurrence and survival for Asian breast cancer patients.

Biosci Rep. 2020 Dec 23;40(12). doi: 10.1042/BSR20202794.

The current clinical value of the DCIS Score.

Oncology (Williston Park). 2014 May;28 Suppl 2:C2, 1-8, C3.

Defining Risk of Late Recurrence in Early-Stage Estrogen Receptor-Positive Breast Cancer: Clinical Versus Molecular Tools.

J Clin Oncol. 2019 Jun 1;37(16):1365-1369. doi: 10.1200/JCO.18.01933. Epub 2019 Apr 3.

Impact of gene-expression profiling in patients with early breast cancer when applied outside the guideline directed indication area.

Eur J Cancer. 2017 Oct;84:270-277. doi: 10.1016/j.ejca.2017.07.042. Epub 2017 Aug 24.

Genomic Profiling in Node-Positive ER-Positive Early Breast Cancer: Can Tumor Biology Guide Locoregional Therapy?

J Natl Cancer Inst. 2017 Apr 1;109(4). doi: 10.1093/jnci/djw316.

Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.

JAMA Oncol. 2015 May;1(2):158-66. doi: 10.1001/jamaoncol.2015.43.

The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.

JAMA Oncol. 2016 Feb;2(2):217-24. doi: 10.1001/jamaoncol.2015.4377.

Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer.

Oncotarget. 2015 Dec 29;6(42):44593-608. doi: 10.18632/oncotarget.6260.

21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer.

Breast Cancer Res Treat. 2017 Nov;166(1):69-76. doi: 10.1007/s10549-017-4381-7. Epub 2017 Jul 12.

引用本文的文献

HPRT1: a preliminary investigation on its involvement in nasopharyngeal carcinoma.

Discov Oncol. 2024 Nov 6;15(1):624. doi: 10.1007/s12672-024-01506-y.

The Added Prognostic Value of Oncotype Recurrence Score to AJCC Prognostic Staging System in Stage III ER+/HER2- Breast Cancer.

Adv Ther. 2023 Sep;40(9):3912-3925. doi: 10.1007/s12325-023-02566-2. Epub 2023 Jun 29.

Incorporating clinicopathological and molecular risk prediction tools to improve outcomes in early HR+/HER2- breast cancer.

NPJ Breast Cancer. 2023 Jun 28;9(1):56. doi: 10.1038/s41523-023-00560-z.

The Clinical Research and Latest Application of Genomic Assays in Early-Stage Breast Cancer.

Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221117402. doi: 10.1177/15330338221117402.

Circulating Cell-Free DNA Reflects the Clonal Evolution of Breast Cancer Tumors.

Cancers (Basel). 2022 Mar 4;14(5):1332. doi: 10.3390/cancers14051332.

Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India.

South Asian J Cancer. 2021 Dec 31;10(4):213-219. doi: 10.1055/s-0041-1742080. eCollection 2021 Dec.

Miller-Payne Grading and 70-Gene Signature Are Associated With Prognosis of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer After Neoadjuvant Chemotherapy.

Front Oncol. 2021 Sep 24;11:735670. doi: 10.3389/fonc.2021.735670. eCollection 2021.

Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative.

Br J Cancer. 2021 Apr;124(9):1503-1512. doi: 10.1038/s41416-020-01247-z. Epub 2021 Feb 18.

Management of early breast cancer during the COVID-19 pandemic in Brazil.

Breast Cancer Res Treat. 2020 Nov;184(2):637-647. doi: 10.1007/s10549-020-05877-y. Epub 2020 Aug 16.

Simulation Modeling to Extend Clinical Trials of Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Early Breast Cancer.

JNCI Cancer Spectr. 2019 Aug 10;3(4):pkz062. doi: 10.1093/jncics/pkz062. eCollection 2019 Dec.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验